175 related articles for article (PubMed ID: 29457293)
1. Ginsenoside Rh2 inhibits prostate cancer cell growth through suppression of microRNA-4295 that activates CDKN1A.
Gao Q; Zheng J
Cell Prolif; 2018 Jun; 51(3):e12438. PubMed ID: 29457293
[TBL] [Abstract][Full Text] [Related]
2. Curcumin inhibits growth of prostate carcinoma via miR-208-mediated CDKN1A activation.
Guo H; Xu Y; Fu Q
Tumour Biol; 2015 Nov; 36(11):8511-7. PubMed ID: 26032092
[TBL] [Abstract][Full Text] [Related]
3. Ginsenoside Rh2 Mitigates Pediatric Leukemia Through Suppression of Bcl-2 in Leukemia Cells.
Wang X; Wang Y
Cell Physiol Biochem; 2015; 37(2):641-50. PubMed ID: 26344648
[TBL] [Abstract][Full Text] [Related]
4. Ginsenoside Rh2 inhibits hepatocellular carcinoma through β-catenin and autophagy.
Yang Z; Zhao T; Liu H; Zhang L
Sci Rep; 2016 Jan; 6():19383. PubMed ID: 26783250
[TBL] [Abstract][Full Text] [Related]
5. Ginsenoside rh2 inhibits cancer stem-like cells in skin squamous cell carcinoma.
Liu S; Chen M; Li P; Wu Y; Chang C; Qiu Y; Cao L; Liu Z; Jia C
Cell Physiol Biochem; 2015; 36(2):499-508. PubMed ID: 25966742
[TBL] [Abstract][Full Text] [Related]
6. miR-3619-5p inhibits prostate cancer cell growth by activating CDKN1A expression.
Li S; Wang C; Yu X; Wu H; Hu J; Wang S; Ye Z
Oncol Rep; 2017 Jan; 37(1):241-248. PubMed ID: 27878260
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of miR-153 promotes cell proliferation via downregulation of the PTEN tumor suppressor gene in human prostate cancer.
Wu Z; He B; He J; Mao X
Prostate; 2013 May; 73(6):596-604. PubMed ID: 23060044
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of autophagy potentiates anticancer property of 20(S)-ginsenoside Rh2 by promoting mitochondria-dependent apoptosis in human acute lymphoblastic leukaemia cells.
Xia T; Wang J; Wang Y; Wang Y; Cai J; Wang M; Chen Q; Song J; Yu Z; Huang W; Fang J
Oncotarget; 2016 May; 7(19):27336-49. PubMed ID: 27027340
[TBL] [Abstract][Full Text] [Related]
9. Ginsenoside Rh2 inhibits human A172 glioma cell proliferation and induces cell cycle arrest status via modulating Akt signaling pathway.
Li KF; Kang CM; Yin XF; Li HX; Chen ZY; Li Y; Zhang Q; Qiu YR
Mol Med Rep; 2018 Feb; 17(2):3062-3068. PubMed ID: 29207171
[TBL] [Abstract][Full Text] [Related]
10. SS18-SSX-regulated miR-17 promotes tumor growth of synovial sarcoma by inhibiting p21WAF1/CIP1.
Minami Y; Kohsaka S; Tsuda M; Yachi K; Hatori N; Tanino M; Kimura T; Nishihara H; Minami A; Iwasaki N; Tanaka S
Cancer Sci; 2014 Sep; 105(9):1152-9. PubMed ID: 24989082
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-494-3p targets CXCR4 to suppress the proliferation, invasion, and migration of prostate cancer.
Shen PF; Chen XQ; Liao YC; Chen N; Zhou Q; Wei Q; Li X; Wang J; Zeng H
Prostate; 2014 May; 74(7):756-67. PubMed ID: 24644030
[TBL] [Abstract][Full Text] [Related]
12. Ginsenoside 20(S)-Rh2 exerts anti-cancer activity through the Akt/GSK3β signaling pathway in human cervical cancer cells.
Shi X; Yang J; Wei G
Mol Med Rep; 2018 Mar; 17(3):4811-4816. PubMed ID: 29363731
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-34a Attenuates Paclitaxel Resistance in Prostate Cancer Cells via Direct Suppression of JAG1/Notch1 Axis.
Liu X; Luo X; Wu Y; Xia D; Chen W; Fang Z; Deng J; Hao Y; Yang X; Zhang T; Zhou L; Wu Y; Wang Q; Xu J; Hu X; Li L
Cell Physiol Biochem; 2018; 50(1):261-276. PubMed ID: 30282072
[TBL] [Abstract][Full Text] [Related]
14. Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells.
Fujita Y; Kojima K; Hamada N; Ohhashi R; Akao Y; Nozawa Y; Deguchi T; Ito M
Biochem Biophys Res Commun; 2008 Dec; 377(1):114-9. PubMed ID: 18834855
[TBL] [Abstract][Full Text] [Related]
15. Ginkgolide B Inhibits Human Bladder Cancer Cell Migration and Invasion Through MicroRNA-223-3p.
Zhi Y; Pan J; Shen W; He P; Zheng J; Zhou X; Lu G; Chen Z; Zhou Z
Cell Physiol Biochem; 2016; 39(5):1787-1794. PubMed ID: 27744452
[TBL] [Abstract][Full Text] [Related]
16. Re-expression of microRNA-4319 inhibits growth of prostate cancer via Her-2 suppression.
Lin X; Wang Y
Clin Transl Oncol; 2018 Nov; 20(11):1400-1407. PubMed ID: 29633185
[TBL] [Abstract][Full Text] [Related]
17. MiR-639 promoted cell proliferation and cell cycle in human thyroid cancer by suppressing CDKN1A expression.
Lei ST; Shen F; Chen JW; Feng JH; Cai WS; Shen L; Hu ZW; Xu B
Biomed Pharmacother; 2016 Dec; 84():1834-1840. PubMed ID: 27829546
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of prostatic cancer growth by ginsenoside Rh2.
Zhang Q; Hong B; Wu S; Niu T
Tumour Biol; 2015 Apr; 36(4):2377-81. PubMed ID: 25416441
[TBL] [Abstract][Full Text] [Related]
19. Identification of miR-133b and RB1CC1 as independent predictors for biochemical recurrence and potential therapeutic targets for prostate cancer.
Li X; Wan X; Chen H; Yang S; Liu Y; Mo W; Meng D; Du W; Huang Y; Wu H; Wang J; Li T; Li Y
Clin Cancer Res; 2014 May; 20(9):2312-25. PubMed ID: 24610824
[TBL] [Abstract][Full Text] [Related]
20. MiR-323 Inhibits Prostate Cancer Vascularization Through Adiponectin Receptor.
Gao Q; Yao X; Zheng J
Cell Physiol Biochem; 2015; 36(4):1491-8. PubMed ID: 26160610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]